Meeting Details

The 16th Annual General Meeting of Alembic Pharmaceuticals Limited will be held on Wednesday, 5th August 2026 at 4:00 p.m. IST through Video Conferencing (VC) / Other Audio Visual Means (OAVM). The registered office at Alembic Road, Vadodara - 390 003 shall be deemed to be the venue.

Business Items

Ordinary Business:

1. To receive, consider and adopt:

  • Audited Standalone Financial Statements for FY ended 31st March 2026 with Reports of Board of Directors and Auditors
  • Audited Consolidated Financial Statements for FY ended 31st March 2026 with Reports of Auditors

2. To declare Dividend on equity shares for financial year 2025-26

3. To appoint Mr. Pranav Amin (DIN: 00245099) who retires by rotation and offers himself for re-appointment

Special Business:

4. Appointment of Mr. Sujit Jaysukh Bhayani (DIN: 01767427) as Independent Director for 5 years from 18th June 2026 to 17th June 2031 (Special Resolution required)

5. Ratification of remuneration to Cost Auditors M/s. Diwanji & Co. amounting to ₹2.75 Lacs plus applicable tax and out-of-pocket expenses for FY 2026-27 (Ordinary Resolution required)

Key Dates

  • Record Date for Dividend Entitlement: Wednesday, 29th July 2026
  • Dividend Payment Date: On or from 6th August 2026
  • Remote e-Voting Period: Sunday, 2nd August 2026 (9:00 a.m. IST) to Tuesday, 4th August 2026 (5:00 p.m. IST)
  • Unclaimed Dividend Transfer Schedule to IEPF:
  • August 2026: Dividend for 2018-19 declared on 29th July 2019
  • April 2027: Interim dividend for 2019-20 declared on 6th March 2020
  • August 2028: Dividend for 2020-21 declared on 27th July 2021
  • September 2029: Interim dividend for 2021-22 declared on 4th August 2022
  • September 2030: Dividend for 2022-23 declared on 4th August 2023
  • August 2031: Dividend for 2023-24 declared on 22nd July 2024
  • September 2032: Dividend for 2024-25 declared on 5th August 2025

Director Appointment Details

Mr. Sujit Jaysukh Bhayani was appointed as Additional Director designated as Independent Director w.e.f. 18th June 2026. He is Founder and Managing Director of Sudeep Group, holds Bachelor's degree in Chemistry from University of Tulsa, USA, and has over 35 years of pharmaceutical industry experience. Previously served as Director of Dinesh Remedies Limited. He will receive sitting fees for Board/Committee meetings and profit-related commission within limits under Section 197 of Companies Act, 2013.

Voting Arrangements

  • Physical attendance dispensed with; no proxy facility available
  • Remote e-voting through NSDL platform (EVEN: 139826)
  • Scrutinizer: M/s. Samdani Shah & Kabra, Practicing Company Secretaries, Vadodara
  • Results will be displayed on Company website, NSDL website, and stock exchange websites
  • Members must register by 2nd August 2026 to speak or ask questions during AGM

Shareholder Services

  • Registrar & Share Transfer Agent: MUFG Intime India Pvt. Ltd. (MIIPL)
  • Investor grievance email: apl.investors@alembic.co.in
  • SMART ODR Portal registered for dispute resolution: https://smartodr.in/login
  • Members must update KYC details by 24th July 2026 for dividend payments
  • TDS will be deducted on dividend as per Income Tax Act, 2025

Document Availability

Notice and Annual Report available on company website (www.alembicpharmaceuticals.com), BSE website (www.bseindia.com), NSE website (www.nseindia.com), and NSDL website (www.evoting.nsdl.com).